Immuneering Launches Pancreatic Cancer Advisory Board
December 19, 2024 08:00 ET
|
Immuneering Corporation
Immuneering Launches Pancreatic Cancer Advisory Board
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
December 18, 2024 08:45 ET
|
FN Media Group LLC
PALM BEACH, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - One of the most common malignancies in the world today is gastric cancer. The incidence rate is influenced by...
Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025
December 17, 2024 08:00 ET
|
Immuneering Corporation
Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
December 17, 2024 08:00 ET
|
Cargo Therapeutics, Inc.
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Qu Biologics’ Site Specific Immunomodulator Enables CAR T-cell Cancer Efficacy in Solid Tumor
December 16, 2024 08:00 ET
|
Qu Biologics, Inc.
BURNABY, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of...
Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before Surgery and Prevent Metastasis at the 2024 San Antonio Breast Cancer Symposium (SABCS)
December 13, 2024 08:30 ET
|
Medicenna Therapeutics Corp.
Single-agent MDNA11 was more effective than a combination of immune checkpoint inhibitors (anti-mPD1 and anti-mCTLA4) in preventing metastasis and achieving long-term survival in an aggressive mouse...
CG Oncology Announces Pricing of Public Offering
December 12, 2024 20:19 ET
|
CG Oncology Inc.
CG Oncology Announces Pricing of Public Offering
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma
December 12, 2024 08:00 ET
|
Immuneering Corporation
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma
CG Oncology Announces Proposed Public Offering
December 11, 2024 06:17 ET
|
CG Oncology Inc.
CG Oncology Announces Proposed Public Offering
YourUpdateTV speaks with Northwestern Mutual Foundation: Northwestern Mutual Awards 50 Scholarships to Childhood Cancer Survivors and Siblings to Help Fund Higher Education
December 10, 2024 10:00 ET
|
D S Simon
NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Every day, more than 1,000 children worldwide are diagnosed with cancer—a life-changing moment for families. Recently, Steve Radke, president of the...